A United Kingdom supplier, with 1 awarded contract, totalling £3.5bn, most recently 2 months ago.
Managed service contract for IV fluids, topical solutions, and urological products at two NHS sites over 2 years with extension options, under the national Baxter Healthcare agreement.
Two-year managed service contract for IV fluids and related pharmaceutical solutions at NHS Poole and Bournemouth hospitals under the Baxter Healthcare national award.
Nationwide NHS framework for supplying generic pharmaceutical products across multiple regions in three product categories, commencing February 2027 with terms ranging from 8 to 40 months.
Supply compounded aseptic medicines to NHS Scotland healthcare facilities under strict sterility and quality standards.
Procurement for aseptically prepared, dose-banded sterile medicines manufactured to pharmaceutical standards for 2022 delivery.
Opportunity to supply surgical dressings, miscellaneous medical products, and aseptically prepared larvae through a new framework agreement expiring October 2026.
Procurement for medicinal products including generics, branded generics, and proprietary pharmaceuticals under Group 18 classification.
EMPC is extending dose banded chemotherapy services contracts with current suppliers until 30 June 2027, with a new tender expected in late 2026.
Procurement for the supply and delivery of sterile dural repair patches to multiple NHS Trusts for neurosurgical use.
Opportunity to supply vascular grafts and surgical consumables to Northern Ireland's health and social care system through a framework agreement with BSO Procurement and Logistics Service.
